$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000150370722000007 Filed on March 18, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue		$243.3M	$66.84M
YoY Change		-11.65%	-8.32%
Cost Of Revenue		$177.9M	$46.65M
YoY Change		-3.39%	1.41%
Gross Profit		$65.34M	$20.19M
YoY Change		-28.33%	-24.95%
Gross Profit Margin		26.86%	30.21%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$54.84M
YoY Change		-15.64%
% of Gross Profit		83.92%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense		$61.62M
YoY Change		-6.62%
% of Operating Profit
Other Income/Expense, Net		$7.278M
YoY Change		295.54%
Pretax Income		$11.07M
YoY Change		-104.82%
Income Tax		$99.00K
% Of Pretax Income		0.89%
Net Earnings		$26.82M	-$93.54M
YoY Change		-110.15%	252.0%
Net Earnings / Revenue		11.02%	-139.94%
Basic Earnings Per Share		$0.13
Diluted Earnings Per Share		$0.13
COMMON SHARES
Basic Shares Outstanding	192.6M shares	191.6M shares	190.2M shares
Diluted Shares Outstanding		191.6M shares

Balance Sheet

Concept	2021 Q4	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$200.5M	$66.00M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$0.00	$21.39M
YoY Change	-100.0%	0.0%
Intangibles	$2.590M
YoY Change
Long-Term Investments	$212.3M	$229.2M
YoY Change	-7.36%	-14.77%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.413B	$1.918B
YoY Change	-26.35%	-10.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$966.1M	$1.506B
YoY Change	-35.87%	2.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.278B	-$1.303B
YoY Change	-1.92%	25.11%
Common Stock	$1.723B	$1.712B
YoY Change	0.63%	0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$444.5M	$409.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.413B	$1.918B
YoY Change	-26.35%	-10.4%

Cashflow Statement

Concept	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$26.82M	-$93.54M
YoY Change	-110.15%	252.0%
Depreciation, Depletion And Amortization	$54.84M
YoY Change	-15.64%
Cash From Operating Activities	-$6.438M
YoY Change	-120.76%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$413.0K
YoY Change	-909.8%
Cash From Investing Activities	$661.8M
YoY Change	-7964.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$538.0M
YoY Change	-4529.24%
NET CHANGE
Cash From Operating Activities	-$6.438M
Cash From Investing Activities	$661.8M
Cash From Financing Activities	-$538.0M
Net Change In Cash	$117.4M
YoY Change	237.75%
FREE CASH FLOW
Cash From Operating Activities	-$6.438M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#RealEstateInvestmentPropertyNet
CY2021Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	000-55190
CY2021	dei	Entity Registrant Name EntityRegistrantName	NORTHSTAR HEALTHCARE INCOME, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3663988
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	590 Madison Avenue
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	34th Floor
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2021	dei	City Area Code CityAreaCode	212
CY2021	dei	Local Phone Number LocalPhoneNumber	547-2600
CY2021	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	0	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	193600468	shares
CY2021	dei	Auditor Firm AuditorFirmId	248
CY2021	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2021	dei	Auditor Location AuditorLocation	New York, New York
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	200473000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65995000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	10465000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	27575000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	972599000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1483930000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	212309000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	229173000	USD
CY2021Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	0	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	55864000	USD
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	USD
CY2020Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	5000000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3666000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	14735000	USD
CY2021Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	2590000	USD
CY2020Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	26483000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	10771000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	9681000	USD
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	7338000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8318000	USD
CY2021Q4	us-gaap	Assets Assets	1412873000	USD
CY2020Q4	us-gaap	Assets Assets	1918436000	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	929811000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	1416871000	USD
CY2021Q4	nshi	Line Of Credit Related Party LineOfCreditRelatedParty	0	USD
CY2020Q4	nshi	Line Of Credit Related Party LineOfCreditRelatedParty	35000000	USD
CY2021Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	1171000	USD
CY2020Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3851000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	24671000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	38393000	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	3064000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	3941000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	966055000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1506374000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	193120940	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	193120940	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	190409341	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	190409341	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1930000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1904000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1720719000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1710023000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1277688000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1302755000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-486000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	467000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	444475000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	409639000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	2343000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	2423000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	137322000	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	157024000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	446818000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	412062000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1412873000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1918436000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	105955000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	118126000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	130135000	USD
CY2019	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	161084000	USD
CY2021	us-gaap	Other Operating Income OtherOperatingIncome	0	USD
CY2020	us-gaap	Other Operating Income OtherOperatingIncome	198000	USD
CY2019	us-gaap	Other Operating Income OtherOperatingIncome	1959000	USD
CY2021	us-gaap	Revenues Revenues	243277000	USD
CY2020	us-gaap	Revenues Revenues	275348000	USD
CY2019	us-gaap	Revenues Revenues	293178000	USD
CY2019	us-gaap	Interest Expense InterestExpense	68896000	USD
CY2021	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	4667000	USD
CY2020	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	7674000	USD
CY2019	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	7703000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	177936000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	184178000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	181214000	USD
CY2021	us-gaap	Interest Expense InterestExpense	61620000	USD
CY2020	us-gaap	Interest Expense InterestExpense	65991000	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	54000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	65000	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	122000	USD
CY2021	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	11105000	USD
CY2020	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	17170000	USD
CY2019	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	19789000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12691000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16505000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12761000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54836000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65006000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70989000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5386000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	165968000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27554000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	323628000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	514883000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	381325000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7278000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1840000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	79477000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	302000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	6314000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11071000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-229719000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-74130000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3545000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1748000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2780000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-790000	USD
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.03
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	25067000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-261458000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-76960000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.38
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.38
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	191629613	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	191629613	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	189573204	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	189573204	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	189054270	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	189054270	shares
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5386000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-953000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	937000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1814000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-953000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	937000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1814000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	25862000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-263301000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-75936000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1748000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2780000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-790000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24114000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-260521000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-75146000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	744374000	USD
CY2019	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	9899000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	239000	USD
CY2019	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	505000	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	294000	USD
CY2019	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	10746000	USD
CY2019	us-gaap	Dividends Dividends	5413000	USD
CY2019	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	4876000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1814000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	667504000	USD
CY2020	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	9685000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	169000	USD
CY2020	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	234000	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	151000	USD
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	2078000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	937000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	412062000	USD
CY2021	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	10557000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165000	USD
CY2021	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	724000	USD
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2552000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-953000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	446818000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3545000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54836000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65006000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-675000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70989000	USD
CY2019	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	193000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3169000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	165968000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27554000	USD
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	222000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3090000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3015000	USD
CY2021	us-gaap	Straight Line Rent StraightLineRent	-7803000	USD
CY2020	us-gaap	Straight Line Rent StraightLineRent	-441000	USD
CY2019	us-gaap	Straight Line Rent StraightLineRent	467000	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	697000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	125000	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	113000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1662000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1887000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	239000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-139000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1850000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	165000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	169000	USD
CY2021	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	194000	USD
CY2020	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	0	USD
CY2019	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	0	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	79477000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	302000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	6314000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	176000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2371000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	801000	USD
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	10557000	USD
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9685000	USD
CY2019	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9899000	USD
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1756000	USD
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4233000	USD
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-691000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1287000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4859000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	629000	USD
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-985000	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	2853000	USD
CY2019	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	204000	USD
CY2021	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-2680000	USD
CY2020	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	559000	USD
CY2019	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-1087000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-17346000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8479000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6647000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-254000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	5923000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6438000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31018000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25298000	USD
CY2021	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	27773000	USD
CY2020	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	15214000	USD
CY2019	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	22323000	USD
CY2021	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	596414000	USD
CY2020	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	927000	USD
CY2019	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	19618000	USD
CY2021	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	74376000	USD
CY2020	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	0	USD
CY2019	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	818000	USD
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	400000	USD
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	39801000	USD
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	18110000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	35922000	USD
CY2021	nshi	Proceeds From Real Estate Debt Investment Modification Fee ProceedsFromRealEstateDebtInvestmentModificationFee	686000	USD
CY2020	nshi	Proceeds From Real Estate Debt Investment Modification Fee ProceedsFromRealEstateDebtInvestmentModificationFee	0	USD
CY2019	nshi	Proceeds From Real Estate Debt Investment Modification Fee ProceedsFromRealEstateDebtInvestmentModificationFee	0	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-413000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	51000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1479000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	661826000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8415000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4287000	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	26000000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	12800000	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	517618000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20250000	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	51734000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	10465000	USD
CY2019	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	708000	USD
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	35000000	USD
CY2019	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	35000000	USD
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	708000	USD
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	8288000	USD
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2019	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	578000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	608000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	585000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2078000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10746000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	10813000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	4876000	USD
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	724000	USD
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	234000	USD
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	505000	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2552000	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	151000	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	294000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-538020000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12147000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-56699000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	117368000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34750000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-35688000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93570000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94508000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210938000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93570000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	65828000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	53140000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	64163000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	28000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3624000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1779000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2378000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	144000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	112000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	100000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	0	USD
CY2020	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	5000000	USD
CY2019	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	0	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), manages a diversified portfolio of investments in healthcare real estate, owned directly or through joint ventures, with a focus on the mid-acuity seniors housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living facilities (“ILF”) and continuing care retirement communities (“CCRC”), which have independent living, assisted living, skilled nursing and memory care available on one campus. Primarily through joint ventures, the Company is also invested in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but through its joint ventures also has international investments in the United Kingdom. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Company’s sponsor. The Prior Advisor invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of December 31, 2021 and 2020. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of December 31, 2021, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is externally managed and has no employees. On February 28, 2022, the Company’s former Sponsor, DigitalBridge Group, Inc. (NYSE: DBRG) (the “Former Sponsor”), completed the previously announced disposition of its wellness infrastructure platform (the “Sponsor Transaction”). Following completion of the Sponsor Transaction, NRF Holdco, LLC (“NRF” or the “New Sponsor”) (and together with the Company’s Former Sponsor, the Company’s Sponsor as the context requires), owns the Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), as well as its own diversified portfolio of medical office buildings, senior housing facilities, skilled nursing facilities and specialty hospitals. NRF is wholly owned by CWP Bidco LP, an entity affiliated with Highgate, a privately held real estate investment and hospitality management company, and Aurora Health Network LLC, a privately held healthcare-focused investment firm. In addition, upon completion of the Sponsor Transaction, employees of the Company’s Former Sponsor focused on the wellness infrastructure platform became employees of the Company’s New Sponsor. The Company’s Advisor, now a subsidiary of the Company’s New Sponsor, will continue to manage the Company’s day-to-day operations pursuant to an advisory agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through December 31, 2021, the Company raised $2.0 billion in total gross proceeds from the sale of shares of common stock in its continuous, public offerings (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The world continues to experience the broad effects of the coronavirus 2019 (“COVID-19”) pandemic. Throughout the year ended December 31, 2021, the Company's healthcare real estate business and investments were challenged by declines in resident occupancy, lower labor force participation rates, which drove increased labor costs, and inflationary pressures on other operating expenses. These impacts of COVID-19 are expected to last, even as states and municipalities have eased and may further ease restrictions. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continuing impact of the COVID-19 pandemic on the Company’s operational and financial performance will depend on a variety of factors, which may differ considerably across regions and fluctuate over time. An extended recovery period increases </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the risk of a prolonged negative impact on the Company’s financial condition and results of operations. While the Company has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue, and the effects of COVID-19 may also lead to heightened risk of litigation, with an ensuing increase in litigation and related costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, the progression of the global economic recovery from the broad effects of COVID-19 remains difficult for the Company to assess and estimate the future impact of COVID-19 on the Company's results of operations. Accordingly, any estimates of the effects of COVID-19 as reflected or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of the economic recovery from COVID-19 and reassess its effects on the Company’s results of operations and recoverability of value across its assets as conditions change.</span></div>
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65995000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	212300000	USD
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	400000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41884000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210938000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93570000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of COVID-19 as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K. Such estimates may change and the impact of which could be material.</span></div>
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	200473000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	27575000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	16936000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2500000	USD
CY2021	nshi	Finance Lease Payments FinanceLeasePayments	700000	USD
CY2020	nshi	Finance Lease Payments FinanceLeasePayments	700000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	473000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	93000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	60000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	29000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	23000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	27000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	705000	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	46000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	659000	USD
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.062
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2021Q2	nshi	Number Of Properties Sold NumberOfPropertiesSold	2	property
CY2021Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	2590000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	4635000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	21387000	USD
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	0	USD
CY2020Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	2590000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	26402000	USD
CY2021Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	0	USD
CY2020Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	81000	USD
CY2021Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	2590000	USD
CY2020Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	26483000	USD
CY2021	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	1400000	USD
CY2020	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	1900000	USD
CY2021Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne	337000	USD
CY2021Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	337000	USD
CY2021Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree	337000	USD
CY2021Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour	337000	USD
CY2021Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Five DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFive	337000	USD
CY2021Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Five DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	905000	USD
CY2021Q4	nshi	Deferred Costsand Finite Lived Intangible Assets Net DeferredCostsandFiniteLivedIntangibleAssetsNet	2590000	USD
CY2021Q4	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	2030000	USD
CY2020Q4	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	2327000	USD
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	4948000	USD
CY2020Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3798000	USD
CY2021Q4	us-gaap	Incentive To Lessee IncentiveToLessee	3209000	USD
CY2020Q4	us-gaap	Incentive To Lessee IncentiveToLessee	2246000	USD
CY2021Q4	nshi	Utility Deposit Assets UtilityDepositAssets	142000	USD
CY2020Q4	nshi	Utility Deposit Assets UtilityDepositAssets	447000	USD
CY2021Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	442000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	863000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	10771000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	9681000	USD
CY2021Q4	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	D
CY2021Q4	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	D
CY2021	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	13100000	USD
CY2020	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	14400000	USD
CY2021	nshi	Lessor Concession Granted Period Covid19 LessorConcessionGrantedPeriodCOVID19	P90D
CY2021	nshi	Lessor Concession Granted Repayment Period Covid19 LessorConcessionGrantedRepaymentPeriodCOVID19	P12M
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5400000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	166000000	USD
CY2020	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2021Q4	nshi	Acquisition Feeand Expense Cap AcquisitionFeeandExpenseCap	0.060
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13100000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	USD
CY2021Q4	us-gaap	Land Land	121518000	USD
CY2020Q4	us-gaap	Land Land	234706000	USD
CY2021Q4	us-gaap	Land Improvements LandImprovements	17798000	USD
CY2020Q4	us-gaap	Land Improvements LandImprovements	23797000	USD
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	965630000	USD
CY2020Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1389706000	USD
CY2021Q4	us-gaap	Tenant Improvements TenantImprovements	0	USD
CY2020Q4	us-gaap	Tenant Improvements TenantImprovements	16172000	USD
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	8141000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	10653000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	10919000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2535000	USD
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	84813000	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	108055000	USD
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1197900000	USD
CY2020Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1774971000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	225301000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	291041000	USD
CY2021Q4	us-gaap	Real Estate Investments RealEstateInvestments	972599000	USD
CY2020Q4	us-gaap	Real Estate Investments RealEstateInvestments	1483930000	USD
CY2021	us-gaap	Depreciation Depreciation	53500000	USD
CY2020	us-gaap	Depreciation Depreciation	63100000	USD
CY2019	us-gaap	Depreciation Depreciation	62800000	USD
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	5400000	USD
CY2020	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	166000000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	11192000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	11472000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	11759000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	33845000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	89840000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	212309000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	229173000	USD
CY2019Q1	nshi	Equity Method Investment Numberof Facilities Sold EquityMethodInvestmentNumberofFacilitiesSold	11	facility
CY2019Q1	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	118000000	USD
CY2019Q1	nshi	Proceeds From Sale Of Property Held For Sale Net ProceedsFromSaleOfPropertyHeldForSaleNet	4300000	USD
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	400000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	USD
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	18110000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5923000	USD
CY2021	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	74400000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	29495000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	20142000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	20865000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	670775000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	47451000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	155037000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	943765000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8318000	USD
CY2021	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	25140000	USD
CY2021	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	26120000	USD
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	7338000	USD
CY2021	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	10600000	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5780000	USD
CY2020	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	31852000	USD
CY2020	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	29314000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8318000	USD
CY2020	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	9700000	USD
CY2020	nshi	Gain On Settlement Of Share Based Payment GainOnSettlementOfShareBasedPayment	300000	USD
CY2021	nshi	Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees	2700000	shares
CY2021	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	10600000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	230083	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	168917	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	239083	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	223167	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	193250	USD
CY2019Q1	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.000924658
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	5400000	USD
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3000000	USD
CY2019Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	2400000	USD
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	122900000	USD
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2020	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	300000	shares
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2100000	USD
CY2020	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	6.29
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1700000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2800000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-800000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segment
CY2021	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	243277000	USD
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	4667000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	177936000	USD
CY2021	us-gaap	Interest Expense InterestExpense	61620000	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	54000	USD
CY2021	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	11105000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12691000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54836000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5386000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7278000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	79477000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	USD
CY2020	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	275348000	USD
CY2020	us-gaap	Interest Income Operating InterestIncomeOperating	7674000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	184178000	USD
CY2020	us-gaap	Interest Expense InterestExpense	65991000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	65000	USD
CY2020	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	17170000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16505000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65006000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	165968000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1840000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	302000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2019	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	293178000	USD
CY2019	us-gaap	Interest Income Operating InterestIncomeOperating	7703000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	181214000	USD
CY2019	us-gaap	Interest Expense InterestExpense	68896000	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	122000	USD
CY2019	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	19789000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12761000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70989000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27554000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	6314000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3545000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2021Q4	us-gaap	Assets Assets	1412873000	USD
CY2020Q4	us-gaap	Assets Assets	1918436000	USD
CY2021	us-gaap	Noninterest Income NoninterestIncome	243277000	USD
CY2021Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	1500000000	USD
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1774971000	USD
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1931032000	USD
CY2018Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1949997000	USD
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	603082000	USD
CY2020	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	USD
CY2019	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	16645000	USD
CY2021	us-gaap	Real Estate Improvements RealEstateImprovements	31397000	USD
CY2020	us-gaap	Real Estate Improvements RealEstateImprovements	17036000	USD
CY2019	us-gaap	Real Estate Improvements RealEstateImprovements	24701000	USD
CY2021	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	5386000	USD
CY2020	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	165246000	USD
CY2019	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	27021000	USD
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1197900000	USD
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1782822000	USD
CY2019Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1931032000	USD
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	0	USD
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	7851000	USD
CY2019Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	0	USD
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1197900000	USD
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1774971000	USD
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1931032000	USD
CY2021Q4	nshi	Sec Schedule Iii Real Estate Amountof Federal Income Tax Basis Over Cost Basis SECScheduleIIIRealEstateAmountofFederalIncomeTaxBasisOverCostBasis	318200000	USD
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	291041000	USD
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	230814000	USD
CY2018Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	171083000	USD
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	53476000	USD
CY2020	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	63078000	USD
CY2019	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	62798000	USD
CY2021	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	119216000	USD
CY2020	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	USD
CY2019	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	3067000	USD
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	225301000	USD
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	293892000	USD
CY2019Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	230814000	USD
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	0	USD
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	2851000	USD
CY2019Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	0	USD
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	225301000	USD
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	291041000	USD
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	230814000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55864000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55468000	USD
CY2018Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	58600000	USD
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	194000	USD
CY2020	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	0	USD
CY2019	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	0	USD
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	687000	USD
CY2020	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	0	USD
CY2019	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	0	USD
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	-18307000	USD
CY2020	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	-271000	USD
CY2019	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	2427000	USD
CY2021	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	74376000	USD
CY2020	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	USD
CY2019	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	818000	USD
CY2021	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	698000	USD
CY2020	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	125000	USD
CY2019	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	113000	USD
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55864000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55468000	USD
CY2021	dei	Auditor Firm AuditorFirmId	248

Files In Submission

Name	View Source	Status
0001503707-22-000007-index-headers.html	Edgar Link	pending
0001503707-22-000007-index.html	Edgar Link	pending
0001503707-22-000007.txt	Edgar Link	pending
0001503707-22-000007-xbrl.zip	Edgar Link	pending
allocatedpurchasepricea.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nshi-20211231.htm	Edgar Link	pending
nshi-20211231.xsd	Edgar Link	pending
nshi-20211231_cal.xml	Edgar Link	unprocessable
nshi-20211231_def.xml	Edgar Link	unprocessable
nshi-20211231_g1.jpg	Edgar Link	pending
nshi-20211231_g2.jpg	Edgar Link	pending
nshi-20211231_htm.xml	Edgar Link	completed
nshi-20211231_lab.xml	Edgar Link	unprocessable
nshi-20211231_pre.xml	Edgar Link	unprocessable
nshi12312021exhibit211.htm	Edgar Link	pending
nshi12312021exhibit231.htm	Edgar Link	pending
nshi12312021exhibit232.htm	Edgar Link	pending
nshi12312021exhibit233.htm	Edgar Link	pending
nshi12312021exhibit234.htm	Edgar Link	pending
nshi12312021exhibit311.htm	Edgar Link	pending
nshi12312021exhibit312.htm	Edgar Link	pending
nshi12312021exhibit321.htm	Edgar Link	pending
nshi12312021exhibit322.htm	Edgar Link	pending
nshiformofrsuaward-ex1012.htm	Edgar Link	pending
nshiprojecttrevi-ex1017.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2021 Q4 Form 10-K Financial Statement

#000150370722000007 Filed on March 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2021 Q4 Form 10-K Financial Statement

#000150370722000007 Filed on March 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs